tranScrip are delighted that Professor Stephen Holgate has been knighted for his services to medical research in the 2020 Queen’s Birthday Honours List.
Stephen is Medical Research Council (MRC) Clinical Professor of Immunopharmacology at the University of Southampton and is also one of the cofounders of Synairgen, a University of Southampton spin-out company established in 2004 to develop inhaled interferon beta which has proven effective against viral respiratory diseases, including COVID-19.
Amongst Professor Holgate’s many awards, medals and honorary positions from Universities and academic institutions around the world, is a CBE, awarded in the Queen’s New Year Honours 2011 for services to clinical science. Two years ago, he received the President’s Medal from the Royal College of Physicians (RCP) for his personal contribution to public health, particularly air quality, over many decades, as well as his exceptional service to the RCP. In 2016 he chaired an RCP working party that published a landmark report setting out the dangerous impact of air pollution on the UK’s health. The report, “Every breath we take” the lifelong impact of air pollution, revealed for the first time that around 40,000 deaths a year in the UK can be linked directly to air pollution. 23 years ago, he established the AAIR charity which supports research into asthma and allergies.
We would like to congratulate Stephen on receiving this recognition of his work and we look forward to continuing to work with Synairgen on their COVID-19 programme and providing other specialist support services as we have over the last 10 years.
Flic Gabbay, Managing Partner of tranScrip said “I have worked with Stephen for over 30 years on respiratory projects and working parties and most recently for nearly 15 years in Synairgen. tranScrip’s team continues to work closely with Synairgen and we are all thrilled at the news – a more appropriate and humble recipient of a knighthood would be hard to find.”